We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Embryo Kinetics and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01678651
First Posted: September 5, 2012
Last Update Posted: February 24, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
IVI Madrid
August 31, 2012
September 5, 2012
February 24, 2016
August 2012
February 2013   (Final data collection date for primary outcome measure)
time of cell cleavage [ Time Frame: February 2012 ]
Analysis of cell cleavage
Same as current
Complete list of historical versions of study NCT01678651 on ClinicalTrials.gov Archive Site
  • Embryo and oocyte morphology [ Time Frame: February 2012 ]
    Analysis of all oocytes
  • Outcome rates (implantation, pregnancy and miscarriage rate) [ Time Frame: February 2012 ]
    Time requierd to know all the implantation, pregnancy and miscarriage rate
Same as current
Not Provided
Not Provided
 
Embryo Kinetics and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH
Embryo Kinetcis From Embryos Deriving From Egg Donation Cycle With Different Stimulation Protocol: Recombinant FSH vs Human FSH
Different kinetics markers have been proposed to select embryos with higher implantation rates. The effect of external factors on these markers, such as the stimulation protocol should be analyzed. There are two different types of FSH that are commonly used for in vitro fertilization (IVF) in egg donation cycles, recombinant FSH and human FSH. The effect of each kind of hormone on embryo kinetcis is still unknown. The aim of this study is to observe if there is a difference in embryo kinetics and morphology as well as oocyte morphological parameters between the two types of FSH and therefore to analyze if such markers can be used despite of the stimulation protocols chosen.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Embryo Kinetics
  • Procedure: Stimulation with human FSH
    Human FSH
  • Procedure: Stimulation with recombinant FSH
    Recombinant FSH
  • Active Comparator: Human FSH
    Human FSH
    Intervention: Procedure: Stimulation with human FSH
  • Active Comparator: Recombinant FSH
    Recombinant FSH
    Intervention: Procedure: Stimulation with recombinant FSH
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
80
February 2013
February 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

•Egg donation cycles with more than 8MII in oocyte retrieval day

Exclusion Criteria:

  • Male factor
  • Uterine malformations
  • genetic alterations
Sexes Eligible for Study: All
18 Years to 35 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Spain
 
 
NCT01678651
MAD-NB-08-2012-01
No
Not Provided
Not Provided
IVI Madrid
IVI Madrid
Not Provided
Not Provided
IVI Madrid
March 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP